Filing Details

Accession Number:
0000950170-24-005900
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-19 19:32:12
Reporting Period:
2024-01-18
Accepted Time:
2024-01-19 19:32:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1880438 An2 Therapeutics Inc. ANTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331852 S Joseph Zakrzewski C/O An2 Therapeutics, Inc.
1800 El Camino Real, Suite D
Menlo Park CA 94027
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-18 100,000 $19.11 405,880 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 98,199 Direct
Footnotes
  1. These shares are held by Z3 Trust, for which the Reporting Person is a trustee.